GlaxoSmithKline PharmaceuticalsGLAXO 
$33.43-0.28%24h
-0.28%24h
Global rank2513
Market cap$5.66B
Change 7d0.76%
YTD Performance47.29%
SP500 benchmarkOutperform
P/E0.93
P/S14.62
Revenue$387.20M
Earnings$72.72M
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of September 2024, GlaxoSmithKline Pharmaceuticals has a market cap of $5.66B. This makes GlaxoSmithKline Pharmaceuticals the world's 2513th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.44B | 15.89% |
| 2023 | $3.83B | 43.94% |
| 2022 | $2.66B | -24.93% |
| 2021 | $3.54B | 8.17% |
| 2020 | $3.28B | 0.85% |
| 2019 | $3.25B | 6.27% |
| 2018 | $3.06B | 21.75% |
| 2017 | $2.51B | -8.81% |
| 2016 | $2.75B | -17.63% |
| 2015 | $3.34B | 3.61% |
| 2014 | $3.23B | 6.68% |
| 2013 | $3.02B | 38.29% |
| 2012 | $2.19B | 11.46% |
| 2011 | $1.96B | -16.79% |
| 2010 | $2.36B | 45.01% |
| 2009 | $1.63B | 40.09% |
| 2008 | $1.16B | 12.02% |
| 2007 | $1.04B | -11.67% |
| 2006 | $1.17B | 3.67% |
| 2005 | $1.13B | 45.67% |
| 2004 | $776.68M | 34.30% |
| 2003 | $578.33M | 87.85% |
| 2002 | $307.88M | - |
GLAXO Market Cap Today is $5.66B -0.28% - 6 Sept 2024
View largest stocks by market cap 
